A Single and Repeat Dose Pharmacokinetics/ Pharmacodynamics (PK/PD) Study to Characterise the Biomarker Response in Healthy Subjects Treated With the Antiinflammatory Macrolide Azithromycin.
Phase of Trial: Phase I
Latest Information Update: 26 Jul 2017
At a glance
- Drugs Azithromycin (Primary)
- Indications Asthma; Bacterial infections; Pelvic inflammatory disorders
- Focus Biomarker; Pharmacodynamics; Pharmacokinetics
- 14 Nov 2011 Actual end date (May 2011) added as reported by ClinicalTrials.gov.
- 14 Nov 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 18 Aug 2011 New trial record